Day one biopharmaceuticals inc DAWN.US Value Analysis

US StockHealth Care
(Powered by Quartr Logo)

DAWN Value Score

3

24

15

Limited Growth
  • AI analysis rates DAWN  with a lower value score of 2.
  • It is mainly due to  unstable operating cash flow, along with potential value may be lower.
  • Over the past 3 months, DAWN has maintained an average value rating of 1.2, slightly higher than the rating of 0.4 over the past 3 years. However, growth opportunities for enterprise value remain relatively low.
  • Compared to all stocks in the Health Care sector, DAWN has a medium value rating.

DAWN Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/03/01 (Weekly Update)

DAWN Financial Forecast

Unit : USD

Update to 2025/5/9 (Quarterly Update)

DAWN Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
-0.69
-
97.1%
29.21M
-
4.9%
39.5%
2024Q2
0.38
-
-192.7%
93.76M
-
229.2%
-53.8%
2024Q1
-0.05
-
-92.5%
8.19M
-
698.2%
0%

Update to 2025/5/10 (Quarterly Update)

DAWN Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

DAWN Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry
Exit

The Backtest Result of DAWN from 2021/05 till Now

-
Cumulative Return
-
Annual Return
-
Volatility
-
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from May, 2021 to May, 2025. (Total Trades: 0)

DAWNSectorUS Overall Market
Wining Rate-45%54%
Avg Return-62.9%72.8%
Avg Profit-197.1%165.9%
Avg Loss--45.1%-34.6%
Avg Risk-Reward Ratio-437%479.2%

Update to 2025/5/10 (Daily Update)

Top 10 High Relevance to DAWN Value Score